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Abstract
Background: In conformational disorders, it is not evident which amyloid aggregates affect
specific molecular mechanisms or cellular pathways, which cause disease because of their quantity
and mechanical features and which states in aggregate formation are pathogenic. Due to the
increasing consensus that prefibrillar oligomers play a major role in conformational diseases, there
is a growing interest in understanding the characteristics of metastable polypeptide associations.
Results: Here, we show that human latexin, a protein that shares the same fold with cystatin C,
assembles into stable spherical amyloid-like oligomers that bind thioflavin-T and congo red similarly
to common amyloid structures but do not evolve into fibrils. Latexin self-assembly correlates with
the formation of a mostly denaturated state rather than with the population of partially structured
intermediates during the unfolding process. The results suggest that unfolding of α-helix 3 might be
involved in the transition of latexin toward amyloidotic species, supporting the notion of the
protective role of the native protein structure against polymerization.
Conclusion: Overall the data herein indicate that latexin could be a good model for the study of
the structural and sequential determinants of oligomeric assemblies in protein aggregation
processes.
Background
Amyloidoses are a group of protein misfolding diseases
characterized by the polymerization of normally innocu-
ous and soluble proteins or peptides into insoluble pro-
teinaceous deposits. No sequence or structural similarities
are apparent between any of the proteins that display the
ability to form amyloid aggregates in diseases like Alzhe-
imer's disease, type II diabetes, systemic amyloidosis or
the transmissible spongiform encephalopaties [1,2].
There is a striking difference between the amounts of amy-
loid depositions in various types of amyloid disorders. In
systemic lysozyme amyloidosis, for example, the deposits
can grow to kilogram quantities in the liver [3,4], whereas
in neurodegenerative diseases, where the quantity of
aggregates can be almost undetectable in some cases [5],
there is no clear correlation between the amount of amy-
loid deposition and the clinical severity of the disease. In
Alzheimer's patients, a significant cognitive impairment
was observed in the absence of noticeable amyloid depos-
its in the brain, although the levels of soluble amyloid oli-
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Evidence is accumulating that prefibrillar aggregates are
cytotoxic both in vivo and in vitro [7-9], although this
question is still open to debate. It still is not evident, how-
ever, which particular amyloid structures induce cell death
by specific molecular mechanisms and which play the role
of "inert" material and cause disease due to their quantity
or mechanical properties. In spite of extensive studies of
the fibrillar state, mainly by solid state NMR and X-ray dif-
fraction, scarce structural information is available, and
there is an increasing interest in the understanding of the
biochemical and biophysical properties of metastable
polypeptide associations preceding the aggregated states
of proteins. Here, we characterize the conformational sta-
bility of latexin, an endogenous vertebrate carboxypepti-
dase inhibitor, and show that it associates into metastable
oligomers with amyloidotic properties. Human latexin
consists of two topologically equivalent subdomains,
each one with a cystatin-like topology, consisting of an α-
helix enveloped by a curved β-sheet. These subdomains
are packed against each other through the helices and
linked by a connecting segment encompassing a third α-
helix [10,11]. Latexin adds up to other proteins unrelated
to any known human disease able to form assemblies
with the characteristics of amyloid [12]. Latexin oligomer-
ization does not depend on the population of partially
structured conformations but probably on the transition
of a native helical structured region to an unfolded con-
formation under conditions that are selectively unfavora-
ble for the folding and nativeness of this polypeptide. In
this particular case, conditions promoting self-assembly
into highly stable oligomers do not promote further evo-
lution into fibrillar structures suggesting that, in protein
deposition, the intermolecular contacts responsible for
the final, usually highly ordered, structure of protein
aggregates could not necessarily coincide with those pro-
moting the formation of the initial oligomeric assemblies,
which may have important consequences for the thera-
peutics of amyloid diseases.
Results
Conformational stability of latexin
The far-UV circular dichroism (CD) spectrum of latexin
recorded under native conditions is consistent with the
recently determined 3D crystal structure, which corre-
sponds to a well-structured protein with an α/β topology
[11]. According to the CD spectra this globular structure is
progressively lost, however, in the presence of increasing
concentrations of urea (Figure 1A). The dependence of
secondary structure on urea concentration, measured as
the mean residue ellipticity at 220 nm, is shown if Figure
1B. The equilibrium denaturation curve presents a single
sigmoidal transition corresponding to a two-state unfold-
ing reaction with a midpoint at 4.1 M urea. This contrasts
with a much lower transition midpoint (2.3 M urea)
deduced from the sigmoidal curve representing the urea-
induced changes in the intrinsic fluorescence of tryp-
tophan residues in latexin, an alternative and even better
reporter of tertiary structural changes. The difference in
the two transition midpoints is usually associated with the
presence of an intermediate state whose population can
be calculated from the normalized unfolding curves (Fig-
ure 1B, broken line). The intermediate state forms
between 1.5 and 6.5 M urea concentration with a maxi-
mum population at 3.5 M. At this urea concentration the
intermediate keeps most of the secondary structure of the
native latexin. It is worth mentioning that latexin exhibits
a striking asymmetry of tryptophan distribution between
its two subdomains. All five tryptophan residues are
located in the second subdomain of latexin, four of them
shielded at the interface between both subdomains, the
remaining tryptophan being exposed to the solvent and
presumably contributing little to variations in fluores-
cence upon unfolding (Figure 1C). Therefore, changes in
fluorescence emission may only reflect local conforma-
tional rearrangements, such as a loss of contacts between
subdomains, rather than a global unfolding of the protein
or of one of its subdomains. This is also likely from the
study of binding of latexin to TNS (2-p-toluidinylnaph-
thalene-6-sulfonate), a dye used to probe the exposure in
partially folded states of previously hidden hydrophobic
clusters. TNS emission spectra were recorded as a function
of urea concentration and no significant binding could be
detected in the folded (0 M urea) and completely
unfolded (9 M urea) states or in the range 3–4 M urea
where the intermediate maximally populates (data not
shown).
Latexin self-association
In a number of cases, in particular for cystatins [13], the
appearance of folding intermediates has been linked to
the self-association of polypeptides into oligomers that
further evolve to yield insoluble amyloid-like structures.
To asses whether the accumulation of an intermediate
during the unfolding of latexin could result in the forma-
tion of stable oligomeric species and to simultaneously
detect the formation of oligomers of different sizes, sam-
ples of latexin incubated for 24 h at different urea concen-
trations were analyzed by SDS-PAGE electrophoresis. The
results shown in Figure 2 demonstrate that latexin self-
associates into SDS-resistant oligomers (dimers, tetramers
and higher molecular weight species) in an urea-depend-
ent manner. SDS-resistant self-associated latexin oligom-
ers start to appear at 3–4 M urea and accumulate
maximally at 6–7 M urea. A decrease in oligomer popula-
tion is observed at higher urea concentrations. 9 M urea
results in strong denaturing conditions where only very-
tight interactions can be maintained. In this denaturant
concentration the oligomeric forms are mostly consti-
tuted by dimeric species, whereas larger associationsPage 2 of 11
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suggesting that the higher order oligomers are formed by
multiple of two polypeptide chains and, that the contacts
within a dimmer are stronger than between dimers. Inter-
estingly enough, during amyloidogenesis of the human
cystatin stefin B, dimers have been shown to be the ini-
tially formed species and subsequent oligomerization
could involve the direct association of these bulding
blocks into tetrameric and higher order species in which
dimers become entwined [14]. The two cysteine residues
in latexin are not involved in a disulfide bond in the
native state and neither are responsible for the association
of latexin in the presence of urea since the distribution of
oligomers does not change in the presence of 2-mercap-
toethanol. The distribution of the oligomeric species in
samples incubated in the presence of urea, does not
change significantly upon removal of the denaturant indi-
cating that the aggregation is not reversible. From the
comparison of the polymerization and unfolding data it
can be inferred that, in the particular case of latexin, oli-
gomerization at low urea concentrations is unfavorable
because protein folding competes with and suppresses self
assembly whereas the significant decrease in the amount
of oligomers at urea concentrations above 7 M indicates
that high chaotropic agent concentrations are unfavorable
to both the native and self-assembled states of latexin.
To understand the conformational changes occurring dur-
ing oligomerization, samples incubated for 24 hours at 0
M and 6 M urea were desalted and their far-UV circular
dichroism spectra compared with that of fresh samples
containing the same amount of urea (Figure 3). The CD
spectrum of the incubated and fresh samples are indistin-
SDS-PAGE electrophoresis of latexin in various concentra-tions of ureaFigure 2
SDS-PAGE electrophoresis of latexin in various con-
centrations of urea. A) Isolated recombinant latexin was 
incubated at 1 mg/ml for 24 hours at room temperature at 
increasing urea concentrations. The incubation mixtures 
were analyzed by electrophoresis in 12% SDS-PAGE. B) 
Latexin incubated at 6 M urea for 24 hours at room temper-
ature and after the urea was removed and incubated for 12 
hours.
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Conformational properties of latexinFigure 1
Conformational properties of latexin. A) CD spectrum 
of latexin at increasing urea concentrations. B) Overlay of 
the urea denaturation curve monitored by intrinsic fluores-
cence and by far UV-CD. The difference in the two transition 
midpoints is usually associated with the presence of an inter-
mediate state whose population is theoretically calculated 
from the normalized unfolding curves. C) 3D structure of 
latexin (2BO9). The five triptophans (red) are located in the 
C-terminal subdomain (light blue and green) and the region 
corresponding to the main hot spot is located in the alpha-
helix 3 (green).
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M urea incubated sample is typical of a largely extended β-
sheet conformation as revealed by the single negative
band at 217–220 nm. This spectrum differs in shape from
the native conformation of latexin, which is also rich in β-
sheet structure. According to the estimation of protein sec-
ondary structure content using the Contin method with
the CDPro suite [15], 6 M urea incubated latexin is devoid
of any α-helical secondary structure. Accordingly, this
sample after urea removal does not exhibit any inhibitory
activity against carboxypeptidase A (data not shown),
indicating the absence of molecules in native conforma-
tion in the protein solution and confirming the irreversi-
bility of the aggregation process. The fresh 6 M urea
sample displays a CD spectrum corresponding to the
much more unfolded conformation already commented
upon in Figure 1A. This suggests that the self-association
of latexin probably begins with the establishment of inter-
molecular interactions between primary unfolded molec-
ular segments in the monomeric species that lead to the
subsequent build up of a predominant, highly stable, β-
sheet conformation.
Amyloid-like features of latexin oligomers
The stability and the extended β-sheet conformation of
latexin self-assemblies suggested that they might have
amyloid-like properties. Binding of thioflavin-T (Th-T) to
amyloid aggregates induces a large increase in the fluores-
cence of Th-T relative to the free dye [16]. In a binding
assay of Th-T to latexin previously incubated for 24 hours
in the presence of different urea concentrations, changes
in the fluorescence intensity of the dye at 485 nm are only
detected above 2 M urea, with a maximum relative
increase at 6 M urea and a progressive decrease at higher
urea concentrations (Figure 4A). Incubation of latexin at
concentrations above 20 μM suffices to promote the for-
mation of Th-T positive species after one day in 6 M urea
(Figure 4B). This agrees with the proposal of the existence
of a critical concentration for amyloid assembly, which is
specific for each particular system [17], since a linear cor-
relation exists between the formation of Th-T binding
forms and the initial amount of protein in the solution
above the 20 μM threshold.
Congo red is another amyloid dye, with an absorbance
maximum at 490 nm, that increases and shifts to red upon
binding to amyloid material. We assayed congo red bind-
ing to latexin after protein incubation for one day at dif-
ferent chaotropic agent concentrations. In a fashion very
similar to what is observed with Th-T, maximum binding
occurs at 6 M urea whereas little binding is detected in
protein solutions below 2 M urea and the binding
decreases in solutions above 6 M urea (Figure 4A). Latexin
incubated at 6 M urea promoted a maximum change in
the congo red spectra at 533 nm, similar to that observed
for aged solutions of Aβ amyloid peptide [18]. The bind-
ing of latexin solutions to both amyloidotic dyes closely
correlates with the amount of oligomeric forms they con-
tain, as analyzed by SDS-PAGE. In agreement with the CD
data, this indicates that latexin oligomers display amy-
loid-like conformations. Importantly, the formation of
these species correlates with the loss of secondary struc-
ture, but not with the formation of an intermediate or the
population of native latexin. This observation is evident
from the comparison of the traces in Figures 4A and 1B.
The morphologies of the latexin species formed under dif-
ferent experimental conditions were examined by trans-
mission electron microscopy (EM) (Figure 5). In
agreement with the above mentioned results, little depo-
sition or particles were detected for latexin incubated 24 h
in solutions below 2 M urea. Latexin incubated in 6 M
urea exhibited numerous roughly spherical aggregates
with average diameter of 18 nm (with larger particles
reaching diameters up to 45 nm) whereas samples incu-
bated in 9 M urea mainly display amorphous aggregates.
To determine if the morphology of oligomers formed at 6
M urea evolve with time, samples of latexin incubated for
one week and one month were imaged using EM. As can
be seen in Figure 5B, the round-shaped oligomers tend to
grow in size and co-associate in chains and networks after
one week and the observation is even more clear after one
month incubation. No evolution to fibrillar structures was
observed in the preparation.
Latexin secondary structural changes after 24 hour incuba-tion in urea monitored by CDFigure 3
Latexin secondary structural changes after 24 hour 
incubation in urea monitored by CD. Far-UV circular 
dichroism spectra were measured at 25°C for samples at 0 M 
urea incubated 24 hours; 6 M urea incubated 24 hours; 6 M 
urea not incubated.
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Binding of amyloid dyes by latexinF gure 4
Binding of amyloid dyes by latexin. A) Changes in the fluorescence emission of Th-T and in congo red absorbance upon 
binding to latexin (0.1 mg/ml) after 24 hours incubations at various concentrations of urea and at 25°C. B) Th-T fluorescence 
at 485 nm at various latexin concentrations. (Inset) Fluorescence emission spectra of th-T at various latexin concentrations.
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BMC Structural Biology 2007, 7:75 http://www.biomedcentral.com/1472-6807/7/75A "hot spot" of aggregation in α-helix 3 of latexin
Polypeptide sequences appear to contain local regions
that are "sensitive" for aggregation. It is possible to
describe with considerable accuracy the in vitro amyloid
aggregation propensities of polypeptides using algorithms
that take into account the physico-chemical properties of
their sequences [19-21]. This leads directly to the defini-
tion of "hot spot" of aggregation as a certain region that
displays higher aggregation propensity than the rest of the
sequence. Latexin forms oligomeric species from a mainly
unfolded state since oligomerization occurs maximally at
6 M urea where according to the CD and intrinsic fluores-
cence analysis, latexin has lost its 3D structure and most
of its secondary structure elements, being about 80% of
the latexin population in unfolded conformations. Under
these conditions aggregation-prone regions, if present,
may promote and drive the self-association event. Using
AGGRESCAN, an in-house developed algorithm that pre-
dicts sequence-dependent effects on the aggregation of
proteins [22], we detected one main "hot spot" encom-
passing residues 127–156 (Figure 6) located in the α-helix
3 of latexin (see Figure 1C). The prediction is in excellent
agreement with that obtained using TANGO algorithm
[19]. Attempts to synthesize a peptide comprising resi-
dues T134-W149 within the "hot spot" region in order to
confirm its hypothetical critical role in aggregation failed
because of its high intrinsic aggregation tendency. How-
ever, a shorter 8-residue peptide corresponding to the cen-
tral part of the "hot spot", V136-A143 (VLHLAWVA) was
soluble enough in phosphate buffer. Over-night incuba-
tion of the 8-residue peptide at 500 μM in 5 mM sodium
phosphate pH 7.5 yielded well-ordered microcrystals with
average dimensions of 0.75 μm × 0.15 μm (Figure 7A).
Binding of Th-T to VLHLAWVA microcrystals was tested
using fluorescence microscopy. Areas rich in peptidic
material appear stained with Th-T, giving a bright green-
yellow fluorescence against a dark background suggesting
an amyloid-like organization of the peptide in the crystals
(Figure 7C). No fluorescence was detected for the buffer
without sample. The structural analysis of VLHLAWVA
microcrystals by Fourier transform IR shows a strong peak
at 1620 cm-1 dominating the amide I region spectrum.
This feature, together with the presence of an additional
sharp peak at 1690 cm-1, resulting from a splitting of the
main β-sheet signal at 1620 cm-1 and usually used as
diagnostic peak for the presence of antiparallel β-strands,
allows to propose a highly ordered intermolecular β-sheet
structure for the peptidic crystals (Figure 7D). Finally, far-
UV CD analysis further indicates the transition of the pep-
tide from a random conformation to a polymeric β-sheet
structure upon incubation (Figure 7B). The presence of a
new positive signal at 232 nm, usually attributed to aro-
matic contributions, in the incubated sample, strongly
suggests that Trp6 is in a defined conformation and not
randomly exposed to solvent in the assembled structure.
Consequently, the data herein suggest that, although the
sequence stretch containing the "hot spot" is located in a
well folded and highly packed helical structure in the
native protein, it might also be involved in the transition
of latexin from a monomeric globular conformation to
amyloid-like oligomeric structures.
Aggregation profile of human latexinFigure 6
Aggregation profile of human latexin. The aggregation 
profile was generated using the program AGGRESCAN. The 
region that displays the highest aggregation propensity, T134-
W149, is framed. The regular secondary structure elements 
shown, correspond to the human latexin structure, cylinders 
stand for α-helices and arrows for β-strands.
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Representative images of latexin protein incubated at various urea concentrations for more than one dayFigure 5
Representative images of latexin protein incubated 
at various urea concentrations for more than one 
day. A) Representative EM images of latexin samples incu-
bated during: (1) 24 hours at 0 M urea; (2) 24 hours at 6 M 
urea; (3) 24 hours at 9 M urea. B) EM images of latexin sam-
ples incubated at 6 M urea during: (1) 24 hours; (2) one 
week; (3) one month. The scale bar represents 500 nm.
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Analysis of VLHLAWVA peptide self-assemblyFigure 7
Analysis of VLHLAWVA peptide self-assembly. A) An electron micrograph of the VLHLAWVA microcristals. The scale 
bar represents 1 μm. B) CD spectrum of VLHLAWVA after 0 hours of incubation and 24 hours at 25°C in buffer P. C) Thiofla-
vin-T fluorescence of stained material after one day incubation in buffer P. (1) Phase contrast microscopy. (2) Fluorescence 
microscopy under UV-light. D) FTIR spectrum of the non-preincubated peptide in buffer P and the peptide incubated in buffer 
P 24 hours. The positions of the spectral components are estimated from the second derivate analysis.
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It has been proposed that almost every protein, when
incubated under the right conditions, can aggregate [12].
Since globular proteins rarely aggregate from their native
states, their destabilization and subsequent increased
population of unfolded molecules is well established as a
triggering factor in disorders associated with the deposi-
tion of proteins that are globular in their normal func-
tional states [23,24], like β2-microglobulin, lysozyme,
transthyretin and the prion protein. Accordingly, many of
the proteins involved in depositional disorders are mostly
unstructured within the cell [24]. These include amylin,
amyloid-β-protein, and α-synuclein, among others. In
these cases, protein polymerization and deposition does
not require unfolding and can occur by direct self-assem-
bly of the unstructured polypeptide chains. In the last few
years, proteins unrelated to any known human disease
have been found to convert in vitro into higher order struc-
tures that also present a cross-β conformation and fulfill
all characteristics of amyloid fibrils [25-27]. Latexin is a
vertebrate carboxypeptidase inhibitor with an α/β fold,
closely resembling that of cystatins. Interestingly enough,
several members of the cystatin family have been shown
to form stable oligomeric assemblies and amyloid fibrils
[13,28,29].
The latexin fold is destabilized at low urea concentrations
and the protein becomes mostly unfolded above 6 M
urea. A stable equilibrium intermediate populates during
the unfolding reaction of latexin. The intermediate most
likely corresponds to an open form in which the two
domains of latexin have lost their contacts but still con-
serve most of their secondary structure and probably
domain architecture. Nevertheless, this partially folded
form of latexin does not appear to be competent for
polypeptide self-assembly, since its formation does not
overlap with conditions that promote maximum oli-
gomerization. As previously described for myoglobin
[30], the oligomerization of latexin correlates with condi-
tions in which the protein is mostly unstructured, rather
than with environments that generate partially folded
intermediates. In the case of the structurally related cysta-
tin C, the effect of temperature, pH and denaturant in self-
assembly has been assayed [31]. In contrast to latexin,
cystatin C self-assembles through the formation of a par-
tially unfolded intermediate, under conditions quite far
from those leading to the unfolding of the protein. The
process of polymerization involves the initial formation
of a dimer by domain-swapping [32] and subsequent
propagation of this effect to form oligomeric assemblies
[33]. Consistently, stabilization of the monomer by differ-
ent means avoid swapping and further cystatin polymeri-
zation [34]. Although, in the case of latexin dimers are
relevant forms in the oligomerization process, it is
unlikely that they are domain-swapped forms, since these
species essentially keep the same 3D protein structure as
the monomer, while the assemblies of latexin have lost
most of the native organization. Also, according to our
data, oligomer formation by a mechanism in which dim-
ers act as building blocks is more likely than a propagated
(or run-away) mechanism. Overall, latexin differs from
protein models in which polymerization depends on the
population of partially structured conformations, usually
enriched in β-sheet structure [27,35]. Instead, our data
indicate that, like in the case of intrinsically unstructured
proteins, the structural precursors in the first stages of
latexin polymerization correspond to protein regions con-
taining little, if any, secondary structure.
Provided that self-assembly takes place in conditions
where the polypeptide chain is mainly unfolded, the use
of prediction algorithms that forecast aggregation-prone
regions merely from the protein sequence should allow
the detection of the latexin region(s) involved in the for-
mation and maintenance of intermolecular contacts.
According to such programs, the latexin region with the
highest probability to be involved in amyloid-like inter-
molecular contacts comprises residues T134-W149. This
is supported by the observation that the central sequence
of this predicted region, corresponding to the peptide
VLHLAWVA, forms well-ordered microcrystals with amy-
loid properties as analyzed by EM, Th-T binding, CD and
FTIR. The formation of peptide microcrystals in physio-
logical conditions is usually associated with rapid forma-
tion of strong and specific intermolecular interactions. In
the protein context the same strong contacts might
become relevant for the oligomerization process of
latexin. These microcrystals are of interest since their
properties closely resemble those formed by peptides
related to fibril-forming proteins like Alzheimer's amy-
loid-β, tau and prion proteins from which the high reso-
lution atomic structure of a common amyloid cross-beta
spine involving the formation of steric zippers has been
determined [36,37]. Experiments are underway in our lab
to solve the structure of this peptide assembly.
Overall, the data herein indicate that, in the case of
latexin, the formation of oligomeric species occurs maxi-
mally under conditions that are specifically adverse to the
folding of the protein. This can be easily rationalized,
since aggregation-prone regions have their side chains
usually hidden in the inner hydrophobic core of the
native globular protein or already involved in the network
of contacts that stabilizes the secondary and tertiary struc-
ture of polypeptides. Specifically, the VLHLAWVA region
of latexin is located in α-helix 3, where the establishment
of anomalous intermolecular interactions is blocked not
only because it belongs to a secondary structure element,
but also because its side chains participate in the interface
contacts between the two domains of latexin. From thePage 8 of 11
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sufficient to promote the loss of the α-helical structure
and oligomerization, but is probably a prerequisite for
this event to occur. Once in a non-structured context and
exposed to solvent by denaturation, the VLHLAWVA
region is ready for the establishment of intermolecular
contacts as proven by the analysis of the eight-residue
peptide. Thus, latexin constitutes yet another example that
illustrates the protective role played by the protein native
structure against aggregation.
Conclusion
Protein aggregation generates a very broad range of struc-
tures including oligomers, protofibrils, and fibrils. Deter-
mining the role of these so-called "prefibrillar species" in
assembly is of paramount importance, since such com-
plexes have been proposed for many proteins to be
responsible for the cellular toxicity associated with amy-
loid disease [38,39]. Dimeric, tetrameric and higher order
latexin oligomers were visualized and characterized. From
this study, it appears that the latexin system could be an
excellent model for the isolation and deep structural and
biochemical characterization of highly stable low-molec-
ular weight oligomeric species that appear to be the final
association state of latexin under strongly denaturing con-
ditions, despite exhibiting tinctorial and conformational
amyloid-like properties. The drastic conditions in which
latexin self-assemblies only allow for strong intermolecu-
lar contacts to be established and probably prevent the
formation of the specific network of non-covalent interac-
tions needed to evolve into the quasi-crystalline structure
characteristic of amyloid fibrils. Accordingly, urea has
been used to reduce the driving force for Aβ-peptide aggre-
gation, in an effort to isolate stable oligomeric assemblies
[40]. Increasing urea concentrations reduced the average
size of the aggregates, and the morphology of the aggre-
gates changed from linear fibrils to globular oligomeric
structures This behavior indicates that the interactions
involved in the formation of the primary, low molecular
weight oligomers during protein aggregation do not nec-
essarily overlap with those driving the formation and sta-
bilization of higher order fibrillar assemblies. This is
relevant for the therapies of amyloid disease, since it sug-
gests that drugs designed to interfere with the interactions
occurring in amyloid fibrils would not necessarily have a
significant effect in the initial assembly of pre-fibrillar
aggregates, which have been implicated as the toxic spe-
cies in conformational disorders.
Methods
Materials
Recombinant latexin was produced in E. coli and purified
as previously described [11]. The peptide VLHLAWVA was
synthesized by the American Peptide Company, Sunny-
vale, CA. Previously a peptide comprising T134-W149 was
tried to be synthesized by the same company but its high
aggregation tendency made it impossible to obtain it in a
soluble form for further purification. Urea, thioflavin-T
and congo red were purchased from Sigma. Unless other-
wise mentioned, all solutions used for latexin analysis
were made in 50 mM phosphate buffer pH 7.5 (buffer N),
and 5 mM phosphate buffer pH 7.5 was used for peptide
preparations (buffer P). All the experiments were per-
formed at 25°C.
Sample preparation
Unless stated otherwise, oligomeric samples were
obtained by incubating protein at 1 mg/ml in buffer N in
the presence of different concentrations of urea from sev-
eral hours to several days. The peptide VLHLAWVA was
incubated at 500 μM concentration in buffer P for 24 h.
Prediction of sensitive regions for aggregation
To determine which regions of latexin sequence could be
involved in aggregation the in-house developed AGGRES-
CAN software was used [41] and the predictions cross-
checked against TANGO [42] outputs. Both algorithms
detected the sequence stretch around residues 130–150 as
the main region which could be potentially involved in
the aggregation of latexin from a mainly unfolded state
[19,22]. A peptide covering residues V136-A143 (VLH-
LAWVA) was synthesized in order to check experimentally
its relevance for latexin aggregation.
Circular dichroism and fluorescence spectroscopies
Circular dichroism (CD) spectra in the far-UV region were
obtained by using a Jasco-810 spectropolarimeter at
25°C. Spectra were recorded for native proteins and for
proteins after incubation at different urea concentrations
(ranging from 0 to 9 M) at 100 μg/ml protein concentra-
tion. Twenty accumulations were averaged to obtain each
spectrum. The mean residue ellipticity at 220 nm was
plotted versus urea concentration to obtain denaturation
curves. The fitting of the experimental data was performed
using the non-linear, least-squares algorithm provided
with the software KaleidaGraph (Abelbeck Software). The
peptide CD spectra was analyzed immediately upon dilu-
tion and after incubation at 500 μM concentration in
buffer P for 24 h. Tryptophan fluorescence was excited at
280 nm and recorded at 340 nm. For calculation of the
relative population of folded and unfolded species, the
linear-dependence of the fluorescence of both the folded
and unfolded latexin states on the urea concentrations
was included in the fitting of the experimental data.
Dye binding assays
Thioflavin-T binding assays were carried out using aliq-
uots of 100 μl drawn from 1 mg/ml protein samples in
buffer N after 24 h incubation. These aliquots were
diluted into buffer (10 mM sodium phosphate, 150 mMPage 9 of 11
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final volume of 1 ml. Fluorescence data were collected
after five minutes to ensure that thermal equilibrium had
been achieved. Fluorescence emission spectra were
recorded using an excitation wavelength fixed at 440 nm.
The Th-T stained samples were also analyzed under UV
light using a Leica DMBR microscope. Samples were
tested for amyloid-specific congo red binding by the spec-
troscopic band-shift assay as described by Klunk [18].
Briefly, aliquots of 1 mg/ml protein were diluted in reac-
tion solution (5 mM sodium phosphate/150 mM NaCl,
pH 7.0) containing 5 μM congo red and absorption spec-
tra were collected together with negative control solutions
of dye in absence of protein and of protein samples in the
absence of dye, subtracting the absorption of the dye and
the scattering contribution from the samples spectra.
Transmission electron microscopy
Samples containing 1 mg/ml of latexin or 500 μM of VLH-
LAWVA peptide were incubated as above. A 5 μl aliquot
was then placed on carbon-coated copper grids, and
allowed to stand for two minutes. The grids were then
washed with distilled water and stained with 2% (w/v)
uranyl acetate and allowed to stay for two minutes prior
to analysis using a Hitachi H-7000 transmission electron
microscope operating at an accelerating voltage of 75 kV.
ATR-FTIR spectroscopy
The VLHLAWVA peptide was incubated in buffer P for 24
h at room temperature and prepared essentially as previ-
ously described [43]. Briefly, the microcrystals were
lyophilized before analysis to reduce water interference in
the infrared spectra and the sample applied on top of the
germanium crystal in the attenuated total reflection mod-
ule of a Bruker Tensor FT-IR spectrometer. The structure of
the peptide aggregates was then analyzed. For each spec-
trum, 20 interferograms were collected and averaged. All
processing procedures were carried out so as to optimize
the quality of the spectrum in the amide I region, between
1550 cm-1and 1700 cm-1.
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